Kyverna Therapeutics Inc.

KYTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.12

-$0.01 (-0.14%)

At close: Sep 21, 2026, 4:00 PM ET

$7.20

+$0.08 (+1.12%)

Pre-market: Sep 22, 2026, 8:15 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021
Cash & Equivalents	124.09M	96.62M	34.65M	37.74M	76.07M
Short-Term Investments	155.16M	189.36M	22.9M	13.59M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	5.45M	5.26M	3.92M	1.23M	593K
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.7M	4.62M	3.12M	1.93M	1.02M
Total Current Assets	282.95M	290.6M	60.66M	53.25M	77.09M
Property-Plant & Equipment	5.42M	10.66M	10.61M	12.44M	7.81M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.87M	15.92M	14.53M	13.67M	8.4M
Total Assets	293.83M	304.65M	75.2M	66.92M	85.49M
Account Payables	5.31M	4.62M	4.36M	1.45M	773K
Deferred Revenue	n/a	n/a	n/a	n/a	6M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	9.99M	4.88M	9.77M	565K	1.72M
Total Current Liabilities	36.49M	33.76M	19.86M	11.95M	15.93M
Long-Term Debt	24.74M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	6K	110.05M
Total Long-Term Liabilities	25.06M	4.3M	6.16M	8.29M	115.81M
Total Liabilities	61.55M	38.06M	26.02M	20.25M	131.74M
Total Debt	29.03M	8.24M	9.08M	10.56M	5.56M
Book Value	232.28M	266.59M	49.18M	46.68M	-46.25M
Book Value Per Share	5.25	6.95	0.07	1.81	-1.79
Common Stock	1K	n/a	n/a	n/a	n/a
Retained Earnings	-424.83M	-263.52M	-136.04M	-75.68M	-46.78M
Comprehensive Income	97K	105K	4K	-26K	n/a
Shareholders Equity	232.28M	266.59M	49.18M	46.68M	-46.25M
Total Investments	155.16M	189.36M	22.9M	13.59M	552K